期刊文献+

miR-145过表达对宫颈癌细胞辐射敏感性的影响 被引量:5

Effect of miR-145 over-expression on radiosensitivity of cervical cancer cells
下载PDF
导出
摘要 目的:探讨微小RNA(miR)-145过表达增强宫颈癌细胞放疗敏感性的分子机制。方法:运用Lipofectamine 2000将miR-145-mimic转染4株宫颈癌细胞系He La、Ca Ski、C33A和Si Ha,以NC-mimic为阴性对照,并以real-time PCR检测子宫内膜基质细胞(ESC)和4株宫颈癌细胞中miR-145的表达水平;转染的细胞经电离辐射照射后于不同时点运用MTT法和Annexin V-FITC/PI染色法联合流式细胞术分别测定细胞活力和细胞凋亡率;运用免疫荧光检测组蛋白γH2AX的表达水平;Western blot检测细胞中螺旋酶样转录因子(HLTF)的蛋白表达水平。结果:miR-145在ESC中高表达,而在4株宫颈癌细胞中均呈低表达,转染miR-145-mimic后4株宫项癌细胞中miR-145的表达水平显著高于NC-mimic组细胞(P<0.05)。相同条件下,辐照后miR-145过表达的宫颈癌细胞的活力显著低于NC-mimic组细胞,72 h的细胞凋亡率明显增加(P<0.05)。免疫荧光观察结果显示miR-145过表达显著促进电离辐射诱导的γH2AX激活;Western blot结果显示,miR-145过表达显著抑制HLTF的表达,与NC-mimic比较差异有统计学意义(P<0.05)。结论:miR-145在正常子宫内膜上皮细胞中高表达,而在宫颈癌细胞系中低表达;miR-145过表达可显著抑制宫颈癌细胞的活力,促进电离辐射诱导的细胞凋亡。miR-145过表达增强宫颈癌细胞的辐射敏感性,其机制可能与下调HLTF表达、抑制DNA损伤修复、促进细胞凋亡有关。 AIM:To investigate the molecular mechanism of microRNA(miR)-145 enhancing radiosensitivity of cervical cancer cells.METHODS:Cervical cancer lines HeLa,CaSki,C33A and SiHa were transfected with miR-145-mimic and NC-mimic using Lipofectamine 2000 kit,and the expression levels of miR-145 in the cervical cancer lines and endometrial stromal cells(ESC)were detected by real-time PCR.The transfected cells were exposed to X-ray radiation.At different time points,the cell viability and apoptotic rate were measured by MTT assay and flow cytometry with AnnexinV-FITC/PI staining,respectively.The protein levels ofγH2AX and helicase-like transcription factor(HLTF)were monitored by immunofluorescence and Western blot,respectively.RESULTS:High miR-145 levels was found in ESC,while low miR-145 levels were found in HeLa,SiHa,C33A and CaSki cells.The level of miR-145 in the cells transfected with miR-145-mimic was significantly higher than that in the negative control cells(P<0.05).The viability of cervical cancer cells with miR-145 over-expression was notably lower than that of the negative control cells,and the apoptotic rate at 72 h was remarkablely increased(P<0.05)under the same condition.The results of immunofluorescence labeling indicated that the protein level ofγH2AX significantly increased in the cervical cancer cells with miR-145 over-expression exposed to radiation compared with the negative control cells(P<0.05).The results of Western blot indicated that the protein level of HLTF significantly decreased in the cervical cancer cells with miR-145 over-expression compared with the negative control cells(P<0.05).CONCLUSION:miR-145 was highly expressed in normal endometrial epithelial cells,while low expressed in cervical cancer cells.miR-145 over-expression inhibits growth and significantly enhances radiosensitivity of cervical cancer cells.The molecular mechanism is possiblely related to downregulating HLTF expression and inhibiting DNA damage repair,thus resulting in apoptosis.
作者 徐杨 赵丽君 王春 XU Yang;ZHAO Li-jun;WANG Chun(Department of Obstetrics and Gynecology,The Fifth People’s Hospital of Jinan,Jinan 250022,China)
出处 《中国病理生理杂志》 CAS CSCD 北大核心 2018年第4期630-636,共7页 Chinese Journal of Pathophysiology
关键词 宫颈癌 微小RNA-145 辐射敏感性 细胞凋亡 Cervical cancer MicroRNA-145 Radiosensitivity Apoptosis
  • 相关文献

参考文献1

二级参考文献18

  • 1[1]Delgado G, Bundy BN, Zaino R, et al. A prospective surgical pathological study of stage Ⅰ squamous carcinoma of the cervix: a Gynecologic Oncology Group study. Gynecol Oncol, 1990,38:352
  • 2[2]Hopkins MP, Morley GW. Radical hysterectomy versus radiation therapy for stage Ⅰ B squamous cell cancer of the cervix. Cancer, 1991,98:272
  • 3[3]Brewster WR, Monk BJ, Ziogas A, et al. Intent - to - treat analysis of stage Ⅰ b and Ⅱ a cervical cancer in the United States: radiotherapy or surgery 1988 ~ 1995. Obstet Gynecol, 2001, 97:248
  • 4[4]Landoni F, Maneo A, Colombo A, et al. Randomised study of radical surgery rersus radiotherapy for stage Ⅰ b ~Ⅱ a cervical cancer. Lancet,1997,350: 535
  • 5[5]Delgado G, Bundy B, Zaino R, et al. Prospective surgical pathological study of disease free interval in patients with stage Ⅰ b squanous cell carcinoma of the cervix: a Gynecologic Oncology Group study. Gynecol Oncol, 1990, 38:352
  • 6[6]Samlal RAK, van der Velden J, Ketting BW, et al. Disease free interval and recurrence pattern after the Okabayashi variant of Wertheim' s radical hyesterectomy for stage Ⅰ b and Ⅱ a cervical carcinoma. Int J Gynecol Cancer, 1996,6:120
  • 7[7]Schorge JO, Molpus KL, Koelliker D, et al. Stage Ⅰ b and Ⅱ a cervical cancer with negative lymph nodes: the role of adjuvant radiotherapy after radical hysterectomy. Gynecol Oncol, 1997, 66:31
  • 8[8]Sedlis A, Bundy BN, Rotman MZ, et al. A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage Ⅰb carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: a Gynecologic Oncology Group study. Gynecol Oncol, 1997, 73:177
  • 9[9]BermanML, Keys H, CreasmanW, etal. Survival and pattems of recurrence in cevical cancer metastatic to periaortic lymph nodes (a Gynecology Oncology Group study). Gynecol Oncol, 1984,19:8
  • 10[10]Vigliotti AP, Wen BC, Hussey DH, et al. Expanded pelvic radiotherapy fields for treatment of local - regionally advanced carcinoma of the cervix: outcome and complications. Int J Radiat Oncol Biol Phys, 1992, 23(3) :501

共引文献4

同被引文献32

引证文献5

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部